Document is current
Any future updates will be listed below
-
Authors
Johnson, Björn
Monwell, Bodil
Capusan, Andrea Johansson
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 6 December 2023
Accepted: 7 March 2024
First Online: 25 March 2024
Declarations
:
: This study is part of a research project studying the introduction of depot buprenorphine in Sweden, approved by the Swedish Ethical Review Authority (reference no. 2020 − 00796).
: Not applicable.
: Andrea J Capusan has received speaker’s fees, and/or scientific advisory board compensation from Lundbeck, Indivior, Camurus, and DNE Pharma, all outside the scope of the current project.Björn Johnson has no competing interests to declare.Bodil Monwell has no competing interests to declare.
